Prosensa To Present At Upcoming Investor Conferences

Leiden, The Netherlands, Sept. 24, 2013 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) todayannounced presentations at upcoming investor conferences. Hans GCP Schikan, Chief Executive Officer, will present acorporate overview at the BioCentury NewsMakers conference in New York, NY on Friday, September 27th, at 10:30am ET andwill also participate on a Fireside Chat at the Leerink RareDisease Roundtable in New York, NY on Tuesday, October2 nd, at 8:00am ET. A live webcast of the BioCenturypresentation can be accessed through the Investor section of theProsensa corporate website at http://ir.prosensa.eu/events.cfmand will be archived for 90 days.

About Prosensa Holding N.V.

Prosensa (NASDAQ: RNA) is a Dutch biotechnologycompany engaged in the discovery and development of RNA-modulatingtherapeutics for the treatment of genetic disorders. Its primaryfocus is on rare neuromuscular and neurodegenerative disorders witha large unmet medical need, including Duchenne muscular dystrophy,myotonic dystrophy and Huntington's disease.  www.prosensa.com
CONTACT: Prosensa Holding N.V.         Celia Economides, Director IR & Corporate Communications         Phone: +1 917 941 9059         Email: c.economides@prosensa.nl

Prosensa Holding B.V. Logo

More from Press Releases

NFL Pushes for Regulation Following Supreme Court's Sports Gambling Ruling

NFL Pushes for Regulation Following Supreme Court's Sports Gambling Ruling

21st Century Fox Scoops Up Local News Stations

21st Century Fox Scoops Up Local News Stations

Walmart CEO: 'We Are Transforming Globally' With Flipkart

Walmart CEO: 'We Are Transforming Globally' With Flipkart

Three-Part FREE Webinar Series

Three-Part FREE Webinar Series

March 24 Full-Day Course Offering: Professional Approach to Trading SPX

March 24 Full-Day Course Offering: Professional Approach to Trading SPX